These metabolites are also able to break the intestinal barrier and appear in the bloodstream to mediate the development and progression of NAFLD by binding to various nuclear receptors (FXR and pregnane X receptor) in liver cells (Ding et al., 2019). The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.